Genetic-Testing Startup Gets $15.8 Million in Financing
Chinese consumer genetic-testing company 23Mofang raised 100 million yuan ($15.8 million) in series B funding from a group of investors led by Matrix Partners China.
Zhou Kun, chief executive officer of the Chengdu-based startup, told Caixin in a phone interview that the company is considering going public in China’s A-share market or in Hong Kong.
Zhou said the company has raised a total of 200 million yuan in five rounds of financing since its inception in 2015, and proceeds from the newest round of financing will be used to enlarge a test center, boost research and development of products, and expand further into the market.
- 1Chart of the Day: ‘Made in China 2025’ Dropped From List of Local Government Priorities
- 2‘Aquaman’ Makes Huge Splash in China Box Office
- 3Update: Huawei CFO Faces U.S. Fraud Charges, Canadian Court Told
- 4Update: China Logs Record-High Surplus With U.S. Despite Softening Overall Export Growth
- 5It Has Been a Bad Year for the Yuan. 2019 Could Be Worse
- 1Power To The People: Pintec Serves A Booming Consumer Class
- 2Largest hotel group in Europe accepts UnionPay
- 3UnionPay mobile QuickPass debuts in Hong Kong
- 4UnionPay International launches premium catering privilege U Dining Collection
- 5UnionPay International’s U Plan has covered over 1600 stores overseas